A University of Manitoba-led study has successfully eliminated breast-cancer-derived brain tumors in mice, using a drug to penetrate the brain and eliminate metastatic brain tumors. After testing ...

Barclays raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $175 and keeps an Equal Weight rating on the shares. The company’s “strong” Q1 reinforces Quest “as a ...

highlighting the rmPFC as a compelling target for transcranial magnetic stimulation. “Identifying a common brain circuit causally involved in psychotic symptoms suggests that the hippocampus may ...

A recently published study has identified collagen type X α 1 chain (CoL10A1) as a promising target for treating brain metastasis in breast cancer patients. The research, conducted by a team at First ...

Truist analyst David MacDonald raised the firm’s price target on Quest Diagnostics (DGX) to $190 from $182 and keeps a Hold rating on the shares on the heels of solid Q1 results featuring in ...

the brain's resident immune cells, and have identified it as a promising therapeutic target for AD. "Immune checkpoint inhibitors have revolutionized cancer immunotherapy, and it is exciting that ...

While these enzymes play important roles in brain function, they can also contribute to AD progression when they attach to plaques. Drugs that target these enzymes are already used to help with ...

COLUMBUS, Ohio – Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor ... found a new target called ...

The “intuitive” beloved by Demi Moore, Brad Pitt, Fortune 500 CEOs, and Esalen attendees alike, talks about healing from ...

For Engert to suggest that the president’s brain quest was bunk was a bit like John Glenn returning from orbit and telling JFK not to bother with a lunar landing. “He should be an advocate ...